Your browser doesn't support javascript.
loading
Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia.
Robak, Tadeusz; Hellmann, Andrzej; Kloczko, Janusz; Loscertales, Javier; Lech-Maranda, Ewa; Pagel, John M; Mato, Anthony; Byrd, John C; Awan, Farrukh T; Hebart, Holger; Garcia-Marco, Jose A; Hill, Brian T; Hallek, Michael; Eisenfeld, Amy J; Stromatt, Scott C; Jaeger, Ulrich.
Afiliação
  • Robak T; Department of Haematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland.
  • Hellmann A; Department of Hematology, Medical University of Gdansk, Gdansk, Poland.
  • Kloczko J; Department of Haematology, Medical University of Bialystok, Bialystok, Poland.
  • Loscertales J; Haematology, Hospital Universitario La Princesa, IIS-IP Madrid, Spain.
  • Lech-Maranda E; Department of Haematology, Institute of Haematology and Transfusion Medicine, Warsaw, Poland.
  • Pagel JM; Department of Haematology and Transfusion Medicine, Centre of Postgraduate Medical Education, Warsaw, Poland.
  • Mato A; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA.
  • Byrd JC; Center for CLL, University of Pennsylvania and Hackensack University, Philadelphia, PA, USA.
  • Awan FT; Division of Hematology, The Ohio State University, Columbus, OH, USA.
  • Hebart H; Division of Hematology, The Ohio State University, Columbus, OH, USA.
  • Garcia-Marco JA; Department of Haematology/Oncology, Stauferklinikum Schwaebisch Gmuend, Mutlangen, Germany.
  • Hill BT; Hospital U. Puerta de Hierro-Majadahonda, Madrid, Spain.
  • Hallek M; Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Eisenfeld AJ; Department I of Internal Medicine, Centre of Integrated Oncology Koln and Cluster of Excellence on Cellular Stress Responses in Aging (CECAD) University of Cologne, Cologne, Germany.
  • Stromatt SC; German CLL Study Group.
  • Jaeger U; Aptevo Therapeutics, Seattle, WA, USA.
Br J Haematol ; 176(4): 618-628, 2017 02.
Article em En | MEDLINE | ID: mdl-27977057
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Imunoglobulina G / Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Cloridrato de Bendamustina Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Imunoglobulina G / Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Cloridrato de Bendamustina Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article